Moreover, circ-CDYL was reported to increase the portion of epithelial cell adhesion molecule (EPCAM)-positive liver tumor-initiating cells, and a treatment combining traditional approaches and circ-CDYL interference was highly effective in inhibiting the proliferation of HCC cells [33]. This evidence concerns the gene EPCAM and hepatocellular carcinoma.